EP0587775A4 - Induction of ctl responses to foreign antigens expressed in mycobacteria. - Google Patents

Induction of ctl responses to foreign antigens expressed in mycobacteria.

Info

Publication number: EP0587775A4
Authority: EP; European Patent Office
Prior art keywords: mycobacteria; induction; ctl responses; antigens expressed; foreign antigens
Prior art date: 1991-06-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP9292913615A

Other languages

German (de)

French (fr)

Other versions

EP0587775A1 (en

Inventor

Charles K Stover

Cruz Vidal Dela

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

MedImmune LLC

Original Assignee

MedImmune LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-06-06

Filing date

1992-06-01

Publication date

1994-11-02

1992-06-01 Application filed by MedImmune LLC filed Critical MedImmune LLC

1994-03-23 Publication of EP0587775A1 publication Critical patent/EP0587775A1/en

1994-11-02 Publication of EP0587775A4 publication Critical patent/EP0587775A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Public Health (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

EP9292913615A 1991-06-06 1992-06-01 Induction of ctl responses to foreign antigens expressed in mycobacteria. Withdrawn EP0587775A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US71164391A	1991-06-06	1991-06-06
US711643		1996-09-10

Publications (2)

Publication Number	Publication Date
EP0587775A1 EP0587775A1 (en)	1994-03-23
EP0587775A4 true EP0587775A4 (en)	1994-11-02

Family

ID=24858927

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP9292913615A Withdrawn EP0587775A4 (en)	1991-06-06	1992-06-01	Induction of ctl responses to foreign antigens expressed in mycobacteria.

Country Status (4)

Country	Link
EP (1)	EP0587775A4 (en)
AU (1)	AU2185592A (en)
CA (1)	CA2110682A1 (en)
WO (1)	WO1992021376A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994015635A1 (en)	1993-01-11	1994-07-21	Dana-Farber Cancer Institute	Inducing cytotoxic t lymphocyte responses
US7300660B2 (en)	1993-11-23	2007-11-27	The Regents Of The University Of California	Abundant extracellular products and methods for their production and use
ES2313719T3 (en)	1993-11-23	2009-03-01	The Regents Of The University Of California	ABUNDANT EXTRACELLULAR PRODUCTS AND PROCEDURE OF PRODUCTION AND USE OF THE SAME.
US6752993B1 (en)	1993-11-23	2004-06-22	The Regents Of The University Of California	Abundant extracellular product vaccines and methods for their production and use
GB9426153D0 (en) *	1994-12-23	1995-02-22	Medical Res Council	Improvements in or relating to vaccines
US6013660A (en) *	1996-10-02	2000-01-11	The Regents Of The University Of California	Externally targeted prophylactic and chemotherapeutic method and agents
US6686339B1 (en)	1998-08-20	2004-02-03	Aventis Pasteur Limited	Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
AU5366099A (en)	1998-08-20	2000-03-14	Connaught Laboratories Limited	Nucleic acid molecules encoding inclusion membrane protein of (chlamydia)
US6693087B1 (en)	1998-08-20	2004-02-17	Aventis Pasteur Limited	Nucleic acid molecules encoding POMP91A protein of Chlamydia
WO2001030382A1 (en)	1999-10-22	2001-05-03	Aventis Pasteur Limited	Method of inducing and/or enhancing an immune response to tumor antigens
EP1792995A3 (en)	2000-05-08	2007-06-13	Sanofi Pasteur Limited	Chlamydia secretory locus orf and uses thereof
EP1282702B1 (en)	2000-05-10	2006-11-29	Sanofi Pasteur Limited	Immunogenic polypeptides encoded by mage minigenes and uses thereof
DE60127421T8 (en)	2000-08-25	2008-08-28	Chancellor, Masters And Scholars Of The University Of Oxford	INTERNAL CORE OLIGOSACCHARIDE EPITOPES FROM LIPOPOLYSACCHARIDES OF HAEMOPHILUS INFLUENZA AS VACCINES IN THE PROPHYLACTIC TREATMENT OF HAEMOPHILUS INFLUENZAE INFECTIONS
WO2002036777A1 (en)	2000-11-02	2002-05-10	The National University Of Singapore	aopB GENE, PROTEIN, HOMOLOGS, FRAGMENTS AND VARIANTS THEREOF, AND THEIR USE FOR CELL SURFACE DISPLAY
AU2002364161A1 (en)	2001-12-12	2003-06-23	Aventis Pasteur Limited	Enhancement of the immune response using cd36-binding domain
ES2290449T3 (en)	2002-04-09	2008-02-16	Sanofi Pasteur Limited	MODIFIED CEA NUCLEIC ACID AND EXPRESSION VECTORS.
BRPI0923649A2 (en)	2008-12-24	2016-01-19	Netherlands Vaccine Inst	modified streptococcus pneumoniae pneumolysin (ply) polypeptides.
EP2668201A2 (en)	2011-01-28	2013-12-04	Sanofi Pasteur SA	Immunological compositions comprising hiv gp41 polypeptide derivatives
US9090667B2 (en) *	2011-04-18	2015-07-28	Myongji University Industry And Academia Cooperation Foundation	Cyclic peptide from Nonomuraea sp., process for the production thereof, and pharmaceutical composition for the prevention or treatment of mycobacteria related disease comprising the same
SG2014008411A (en)	2011-08-08	2014-03-28	Curelab Oncology Inc	Methods and compositions relating to p62 for the treatment and prophylaxis of cancer
EP2895501B1 (en)	2012-09-17	2017-01-18	Novartis Tiergesundheit AG	Salmonid alphavirus and uses thereof
US9809863B2 (en)	2012-11-02	2017-11-07	Elanco Tiergesundheit Ag	Flavivirus associated with Theiler's disease
WO2014140938A2 (en)	2013-03-14	2014-09-18	Centre Hospitalier Universitaire Vaudois	Immunological methods
RU2016128557A (en)	2013-12-29	2018-02-01	Кьюрлаб Онколоджи, Инк.	METHODS AND COMPOSITIONS RELATED TO p62 / SQSTM1 FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH INFLAMMATION
CA2957258C (en)	2014-08-05	2023-11-07	MabQuest SA	Immunological reagents
WO2017093985A1 (en)	2015-12-05	2017-06-08	Centre Hospitalier Universitaire Vaudois	Hiv binding agents
CA3012075A1 (en)	2016-01-22	2017-07-27	MabQuest SA	Immunological reagents
WO2020012435A1 (en)	2018-07-13	2020-01-16	Lausanne University Hospital	Hiv binding agents
EP3996815A2 (en)	2019-07-15	2022-05-18	Lausanne University Hospital	Hiv binding agents
TWI884296B (en)	2020-08-11	2025-05-21	美商碩騰服務公司	Anti-coronavirus vaccines
CN114315985A (en)	2020-09-29	2022-04-12	硕腾服务有限责任公司	Attenuated porcine epidemic diarrhea virus
US20240390476A1 (en)	2021-08-31	2024-11-28	Zoetis Services Llc	Attenuated alphavirus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988006626A1 (en) *	1987-03-02	1988-09-07	Whitehead Institute For Biomedical Research	Recombinant mycobacterial vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5504005A (en) *	1987-03-02	1996-04-02	Albert Einstein College Of Medicine Of Yeshiva University	Recombinant mycobacterial vaccine

1992
- 1992-06-01 WO PCT/US1992/004538 patent/WO1992021376A1/en not_active Ceased
- 1992-06-01 CA CA002110682A patent/CA2110682A1/en not_active Abandoned
- 1992-06-01 AU AU21855/92A patent/AU2185592A/en not_active Abandoned
- 1992-06-01 EP EP9292913615A patent/EP0587775A4/en not_active Withdrawn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988006626A1 (en) *	1987-03-02	1988-09-07	Whitehead Institute For Biomedical Research	Recombinant mycobacterial vaccine

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANNA ALDOVINI ET AL.: "Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines", NATURE, vol. 351, no. 6326, 6 June 1991 (1991-06-06), LONDON GB, pages 479 - 482 *
Annual meeting on modern approaches to new vaccines, 8th, Cold Spring Harbor, N. Y., September, 1990 *
C.K. STOVER ET AL.: "New use of BCG for recombinant vaccines", NATURE, vol. 351, no. 6326, 6 June 1991 (1991-06-06), LONDON GB, pages 456 - 460 *
See also references of WO9221376A1 *
VIDAL F. DE LA CRUZ ET AL.: "Humoral and cellular immune responses to recombinant Mycobacteria (BCG)", VACCINES 91: MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, 1991, pages 399 - 402 *

Also Published As

Publication number	Publication date
AU2185592A (en)	1993-01-08
EP0587775A1 (en)	1994-03-23
WO1992021376A1 (en)	1992-12-10
CA2110682A1 (en)	1992-12-10

Publication	Publication Date	Title
EP0587775A4 (en)	1994-11-02	Induction of ctl responses to foreign antigens expressed in mycobacteria.
AU583783B2 (en)	1989-05-04	Varying firmness mattress
GB2260898B (en)	1995-11-15	Power slider
HUT66753A (en)	1994-12-28	Novel antibodies and methods for their use
EP0746621A4 (en)	1995-08-21	Expression of proteins on bacterial surface
HK48493A (en)	1993-05-27	Hot water jug
EP0722738A3 (en)	1996-10-23	Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
AU7613291A (en)	1992-11-26	Improvements in or relating to milking apparatus
GB9109435D0 (en)	1991-06-26	Improvements in and relating to cookers
AU652970B2 (en)	1994-09-15	Squamous cell carcinoma-like immunoreactive antigen from human female urine
AU541049B2 (en)	1984-12-13	Cyclopropane carboxylates and their use as insectides
EP0301502A3 (en)	1990-02-28	Fermented milk
AU6813190A (en)	1991-06-20	Reversal of female sexual phenotype in poultry
AU6710790A (en)	1991-05-31	Use of polymerized immunoglobulin to reduce the incidence of false-positive responses in immunoassays
AU7097491A (en)	1991-08-22	Formulated milk for infants analogous to human milk
PL294075A1 (en)	1992-09-21	Gelly preparations dispersible in water
GB9126932D0 (en)	1992-02-19	Improvements in and relating to cookers
AU2151092A (en)	1993-01-08	Vaccines with erythrocytes as antigen carriers
GB9106284D0 (en)	1991-05-08	Improvements in and relating to magnetic separators
ZA926340B (en)	1994-02-21	Induction of CTL responses
GB9108976D0 (en)	1991-06-12	Improvements in or relating to magnetic separators
EP0587765A4 (en)	1994-11-02	Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments.
AU1421492A (en)	1992-10-21	Ovine adipocyte antigens and their use in the immunological control of fat
Marshall	1987	Responses to lactation
JPS5722631A (en)	1982-02-05	Polygonal pearl in cultured pearl

Legal Events

Date	Code	Title	Description
1994-02-04	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1994-03-23	17P	Request for examination filed	Effective date: 19940104
1994-03-23	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1994-10-27	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
1994-11-02	A4	Supplementary search report drawn up and despatched	Effective date: 19940916
1994-11-02	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1994-12-14	18W	Application withdrawn	Withdrawal date: 19941021